Annual Cash & Cash Equivalents
$359.28 M
+$139.54 M+63.50%
December 31, 2023
Summary
- As of February 10, 2025, TXG annual cash & cash equivalents is $359.28 million, with the most recent change of +$139.54 million (+63.50%) on December 31, 2023.
- During the last 3 years, TXG annual cash & cash equivalents has fallen by -$304.32 million (-45.86%).
- TXG annual cash & cash equivalents is now -45.86% below its all-time high of $663.60 million, reached on December 31, 2020.
Performance
TXG Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$398.16 M
+$18.34 M+4.83%
September 30, 2024
Summary
- As of February 10, 2025, TXG quarterly cash and cash equivalents is $398.16 million, with the most recent change of +$18.34 million (+4.83%) on September 30, 2024.
- Over the past year, TXG quarterly cash and cash equivalents has increased by +$86.89 million (+27.92%).
- TXG quarterly cash and cash equivalents is now -48.21% below its all-time high of $768.77 million, reached on September 30, 2020.
Performance
TXG Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TXG Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +63.5% | +27.9% |
| 3 y3 years | -45.9% | -32.2% |
| 5 y5 years | +452.1% | -6.1% |
TXG Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.8% | +63.5% | -32.2% | +81.2% |
| 5 y | 5-year | -45.9% | +63.5% | -48.2% | +81.2% |
| alltime | all time | -45.9% | +650.7% | -48.2% | +751.4% |
10x Genomics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $398.16 M(+4.8%) |
| Jun 2024 | - | $379.82 M(+6.8%) |
| Mar 2024 | - | $355.78 M(-1.0%) |
| Dec 2023 | $359.28 M(+63.5%) | $359.28 M(+15.4%) |
| Sep 2023 | - | $311.26 M(-4.5%) |
| Jun 2023 | - | $325.88 M(-1.9%) |
| Mar 2023 | - | $332.32 M(+51.2%) |
| Dec 2022 | $219.75 M(-62.6%) | $219.75 M(-6.1%) |
| Sep 2022 | - | $233.95 M(-14.7%) |
| Jun 2022 | - | $274.19 M(-12.3%) |
| Mar 2022 | - | $312.49 M(-46.8%) |
| Dec 2021 | $587.45 M(-11.5%) | $587.45 M(-2.2%) |
| Sep 2021 | - | $600.44 M(-3.5%) |
| Jun 2021 | - | $621.96 M(+0.8%) |
| Mar 2021 | - | $617.20 M(-7.0%) |
| Dec 2020 | $663.60 M | $663.60 M(-13.7%) |
| Sep 2020 | - | $768.77 M(+126.2%) |
| Jun 2020 | - | $339.84 M(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $372.43 M(-12.2%) |
| Dec 2019 | $424.17 M(+551.8%) | $424.17 M(-0.8%) |
| Sep 2019 | - | $427.44 M(+662.8%) |
| Jun 2019 | - | $56.03 M(-13.9%) |
| Dec 2018 | $65.08 M(+36.0%) | $65.08 M(-88.1%) |
| Dec 2017 | $47.86 M | - |
| Sep 2017 | - | $546.40 M(+862.7%) |
| Jun 2017 | - | $56.76 M(-2.5%) |
| Mar 2017 | - | $58.23 M(+0.9%) |
| Dec 2016 | - | $57.70 M(-15.2%) |
| Sep 2016 | - | $68.07 M(-36.0%) |
| Jun 2016 | - | $106.35 M(+11.3%) |
| Mar 2016 | - | $95.58 M(+104.4%) |
| Dec 2015 | - | $46.77 M(-84.2%) |
| Sep 2015 | - | $296.37 M(+21.0%) |
| Jun 2015 | - | $244.93 M(-2.1%) |
| Mar 2015 | - | $250.13 M(-33.0%) |
| Dec 2014 | - | $373.14 M |
FAQ
- What is 10x Genomics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for 10x Genomics?
- What is 10x Genomics annual cash & cash equivalents year-on-year change?
- What is 10x Genomics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for 10x Genomics?
- What is 10x Genomics quarterly cash and cash equivalents year-on-year change?
What is 10x Genomics annual cash & cash equivalents?
The current annual cash & cash equivalents of TXG is $359.28 M
What is the all time high annual cash & cash equivalents for 10x Genomics?
10x Genomics all-time high annual cash & cash equivalents is $663.60 M
What is 10x Genomics annual cash & cash equivalents year-on-year change?
Over the past year, TXG annual cash & cash equivalents has changed by +$139.54 M (+63.50%)
What is 10x Genomics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TXG is $398.16 M
What is the all time high quarterly cash and cash equivalents for 10x Genomics?
10x Genomics all-time high quarterly cash and cash equivalents is $768.77 M
What is 10x Genomics quarterly cash and cash equivalents year-on-year change?
Over the past year, TXG quarterly cash and cash equivalents has changed by +$86.89 M (+27.92%)